Hysterectomy Rates in Urban China: A Multicenter Study Examining Links Between Metabolic Disorders and Surgical Procedures in Over 9 Million Women - Takeaways - MDSpire

Hysterectomy Rates in Urban China: A Multicenter Study Examining Links Between Metabolic Disorders and Surgical Procedures in Over 9 Million Women

  • By

  • Yanrui Bi

  • Yuan Ma

  • Jun Zhang

  • Shuchen Wang

  • Qiuyi Zhang

  • Yongxiang Gao

  • Ruomei Hu

  • Nenan Lyu

  • Huaying Wang

  • Bo Wang

  • Yi Ning

  • Ying Gao

  • December 30, 2025

  • 0 min

Share

  • 1

    Hysterectomy is a common surgical procedure for women, often performed for benign conditions, cancers, and pregnancy complications.

  • 2

    This study analyzed over 9 million women's records in China to estimate hysterectomy prevalence and explore links to metabolic disorders.

  • 3

    Metabolic disorders such as obesity, hypertension, and metabolic syndrome may be risk factors for undergoing hysterectomy.

  • 4

    The study included women aged 18 and older, emphasizing the need to understand hysterectomy risk factors in childbearing age.

  • 5

    Geographical variations in hysterectomy rates across China were assessed, highlighting differences in lifestyle and health factors.

Original Source(s)

Hysterectomy Rates in Urban China: A Multicenter Study Examining Links Between Metabolic Disorders and Surgical Procedures in Over 9 Million Women

  • by Yanrui Bi, Yuan Ma, Jun Zhang, Shuchen Wang, Qiuyi Zhang, Yongxiang Gao, Ruomei Hu, Nenan Lyu, Huaying Wang, Bo Wang, Yi Ning, Ying Gao

  • December 30, 2025

Related Content

Couple-level dyslipidemia and embryological and cumulative pregnancy outcomes in IVF/ICSI cycles: a single-center retrospective cohort study

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.